SCHEMBL1642066

SCHEMBL1642066

COC(=O)c1cn(Cc2ccc(Br)cc2)c(=O)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 4/20 0.46
ALDH1A1 P00352 2/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90B1 P14625 1/20 0.46
USP2 O75604 1/20 0.44
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1641959 0.87 KDM4E (0.48) ALDH1A1HSP90AA1HSP90B1KDM4EHPGD
SCHEMBL1641936 0.84 KDM4E (0.57) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1642299 0.82 MAPT (0.47) CYP1A2CYP2C9KDM4EHPGDCA12
SCHEMBL1642110 0.78 HSP90AA1 (0.48) ALDH1A1HSP90AA1HSP90B1KDM4EHPGD
SCHEMBL10048127 0.77 CRHBP (0.49) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL31339591 0.76 CA12 (0.44) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL15180973 0.76 P2RX3 (0.53) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL1641394 0.76 CNR1 (0.53) ALDH1A1HSP90AA1HPGD
SCHEMBL1642259 0.76 CNR1 (0.60)
SCHEMBL1641929 0.74 CRHBP (0.61) ALDH1A1KDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098324-A1 PROLYL HYDROXYLASE INHIBITORS GLAXOSMITHKLINE LLC 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098324-A1 PROLYL HYDROXYLASE INHIBITORS HIF1AN, EGLN2, EGLN3 MAPK10 3777/4885ALDH1A1 227/4885HSP90AA1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.